Artia Global Partners’s Biogen BIIB Stock Holding History

Artia Global Partners’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.98M	Hold	18,437	–	–	0.74%	31
2026 Q1	$3.38M	Buy	+18,437	New	+$3.4M	0.68%	29
2023 Q3	–	Sell	-52,275	Closed	-$14.9M	–	29
2023 Q2	$14.9M	Sell	52,275 -27,725	-35%	-$8.25M	5.13%	4
2023 Q1	$22.2M	Buy	80,000 +50,000	+167%	+$13.8M	8.22%	3
2022 Q4	$8.31M	Buy	+30,000	New	+$8.47M	3.17%	9

Other funds holding BIIB

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Artia Global Partners's BIIB Position: Q2 2026 in Review

Artia Global Partners held its Biogen (BIIB) position steady in Q2 2026 at 18,437 shares worth $3.98M. The position accounts for 0.74% of the portfolio, ranked #31.

Artia Global Partners first reported a position in BIIB in Q4 2022 and has held it in 5 quarters since. The position peaked at $22.2M in Q1 2023. 1,043 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

Artia Global Partners held 18,437 shares of Biogen worth $3.98M as of Q2 2026.
Artia Global Partners left its Biogen share count unchanged in Q2 2026.
Biogen made up 0.74% of Artia Global Partners's portfolio in Q2 2026, its #31 holding.
Artia Global Partners first reported a position in Biogen in Q4 2022 and has held it in 5 quarters since.
Artia Global Partners's Biogen position peaked at $22.2M in Q1 2023.
1,043 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on Artia Global Partners's 13F filing for Q2 2026, filed 14 Aug 2026.